MedPath

牡丹江恒远药业股份有限公司

Ownership
-
Established
2004-03-03
Employees
-
Market Cap
-
Website
http://www.hyyygs.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

7

NMPA:7

Drug Approvals

Montelukast Sodium Chewable Tablets

Product Name
孟鲁司特钠咀嚼片
Approval Number
国药准字H20254126
Approval Date
May 13, 2025
NMPA

Montelukast Sodium Chewable Tablets

Product Name
孟鲁司特钠咀嚼片
Approval Number
国药准字H20254127
Approval Date
May 13, 2025
NMPA

Mesalazine

Product Name
美沙拉秦
Approval Number
国药准字H20066027
Approval Date
Sep 19, 2024
NMPA

Montelukast Sodium Tablets

Product Name
孟鲁司特钠片
Approval Number
国药准字H20244582
Approval Date
Jul 30, 2024
NMPA

Montelukast Sodium

Product Name
孟鲁司特钠
Approval Number
国药准字H20060366
Approval Date
May 28, 2024
NMPA

Bezafibrate

Product Name
苯扎贝特
Approval Number
国药准字H20083110
Approval Date
Apr 9, 2018
NMPA

Cefpirome Sulfate

Product Name
硫酸头孢匹罗
Approval Number
国药准字H20060532
Approval Date
Apr 28, 2006
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.